About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DIVIDEND DETAILS
Dividend Details      
Natco Pharma Ltd.
Dividend DateRecord DateDividend %Dividend AmountInterim / Final / Dividend
20 Nov 202520 Nov 2025751.5Interim
19 Aug 202519 Aug 20251002Interim
18 Feb 202518 Feb 2025751.5Interim
27 Nov 202427 Nov 2024751.5Interim
23 Aug 202423 Aug 20241503Interim
26 Feb 202426 Feb 202462.51.25Interim
24 Nov 202324 Nov 202362.51.25Interim
22 Aug 202322 Aug 20233507Interim
21 Feb 202321 Feb 202362.51.25Interim
21 Nov 202222 Nov 202237.50.75Interim
19 Aug 202222 Aug 20221753.5Interim
24 Feb 202225 Feb 20221002Interim
23 Nov 202124 Nov 2021250.5Interim
24 Aug 202125 Aug 20211002Interim
22 Feb 202123 Feb 2021501Interim
(Page 1 of 1)
Previous || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.